Home
About
Services
Partners
Client Portfolio
News
Contact
Blackstone turns up heat on hotelier Unizo with tender offer
October 15, 2019
Exclusive: Deutsche Bank took years to flag suspect Danske money flows – source
October 15, 2019
0
J&J bumps up full-year profit view on strength of cancer drugs
Published by
Muller&Green
at
October 15, 2019
Categories
RSS
Tags
Johnson & Johnson on Tuesday boosted its full-year adjusted profit forecast, as multi-billion dollar sales of its cancer drugs Darzalex and Imbruvica helped it beat estimates for third-quarter profit.
Powered by
WPeMatico
Muller&Green
Related posts
October 3, 2024
Tesla Is Recalling More Than 27,000 Vehicles. Here’s Why
Read more
October 2, 2024
From Shoes to Alcohol, These Products Will Be Impacted by the Dockworkers’ Strike
Read more
September 30, 2024
Gavin Newsom Blocks Contentious AI Safety Bill in California
Read more